VOYA Investment Management
AUPH icon

VOYA Investment Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

VOYA Investment Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$638K Buy
37,579
+2,105
+6% +$33.6K ﹤0.01% 1706
2026
Q1 		$526K Sell
35,474
-401
-1% -$5.86K ﹤0.01% 1695
2025
Q4 		$572K Buy
35,875
+291
+0.8% +$4.13K ﹤0.01% 1685
2025
Q3 		$393K Sell
35,584
-31,216
-47% -$341K ﹤0.01% 1876
2025
Q2 		$566K Sell
66,800
-2,887
-4% -$23.1K ﹤0.01% 1837
2025
Q1 		$560K Buy
69,687
+8,999
+15% +$72.9K ﹤0.01% 1818
2024
Q4 		$545K Sell
60,688
-4,292
-7% -$35K ﹤0.01% 1902
2024
Q3 		$476K Sell
64,980
-9,449
-13% -$58.6K ﹤0.01% 2014
2024
Q2 		$425K Buy
74,429
+8,295
+13% +$43.7K ﹤0.01% 2091
2024
Q1 		$331K Buy
66,134
+11,810
+22% +$80.1K ﹤0.01% 2202
2023
Q4 		$488K Sell
54,324
-310
-0.6% -$2.55K ﹤0.01% 2083
2023
Q3 		$425K Buy
54,634
+601
+1% +$5.88K ﹤0.01% 2126
2023
Q2 		$523K Buy
54,033
+2,252
+4% +$23.4K ﹤0.01% 2061
2023
Q1 		$568K Sell
51,781
-699
-1% -$6.16K ﹤0.01% 1978
2022
Q4 		$227K Hold
52,480
– – ﹤0.01% 2512
2022
Q3 		$395K Buy
52,480
+1,751
+3% +$15.2K ﹤0.01% 2172
2022
Q2 		$510K Buy
+50,729
New +$567K ﹤0.01% 1828

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VOYA Investment Management's AUPH Position: Q2 2026 in Review

VOYA Investment Management increased its Aurinia Pharmaceuticals (AUPH) stake by 5.9% in Q2 2026, buying an estimated $33.6K and bringing the position to 37,579 shares worth $638K. The position accounts for ﹤0.01% of the portfolio, ranked #1706.

VOYA Investment Management first reported a position in AUPH in Q2 2022 and has held it in 17 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • VOYA Investment Management held 37,579 shares of Aurinia Pharmaceuticals worth $638K as of Q2 2026.
  • VOYA Investment Management bought 2,105 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $33.6K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1706 holding.
  • VOYA Investment Management first reported a position in Aurinia Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.